HMBOX1通过PTPN1介导的AKT1酸化抑制肝细胞癌的进展
Chenning Zhang1, Yu Jiang1, Jiahui Liu1
1Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250013, P.R. China.
Oncology reports
|January 23, 2026
概括
含有1 (HMBOX1) 的家庭盒在肝细胞癌 (HCC) 中是下调的. 过度表达HMBOX1抑制HCC细胞的增殖和迁移,揭示了针对HMBOX1/PTPN1/AKT1.1的新疗法途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是一种普遍存在的原发性肝癌,复发率高,有效治疗方法有限.
- 含有HMBOX1的Homeobox1 (HMBOX1) 与瘤发生有关,但其在HCC中的作用尚不清楚.
- 确定新的治疗点对于改善HCC患者的治疗结果至关重要.
研究的目的:
- 为了研究HMBOX1在肝细胞癌中的表达和功能.
- 阐明HMBOX1在HCC中的作用背后的分子机制.
- 探索HMBOX1/PTPN1/AKT1轴作为HCC的治疗点的潜力.
主要方法:
- 对HMBOX1表达的公共数据库和组织微阵列的分析.
- 在体外测试 (细胞计数套件-8,伤口愈合,殖民地形成) 以评估HMBOX1在HCC细胞系中的功能.
- 蛋白质组学,生物信息学,西部抹杀和体内瘤载体实验以确定分子途径.
主要成果:
- 与正常组织相比,HMBOX1在HCC组织中显著下调.
- 过度表达HMBOX1抑制HCC细胞的增殖和迁移; HMBOX1沉默促进这些特征.
- HMBOX1/PTPN1/AKT1信号通路被确定为HCC进展的关键调节器.
结论:
- 在肝细胞癌中,HMBOX1充当瘤抑制剂.
- HMBOX1/PTPN1/AKT1轴代表了一种抑制HCC进展的新途径.
- 这一途径为肝细胞癌治疗提供了潜在的新治疗点.
相关概念视频
01:02Phosphorylation
53.7K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.7K
00:46Feedback Inhibition
56.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
02:27Nonsense-mediated mRNA Decay
11.7K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.7K
02:07Tumor Progression
7.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
01:30Enzyme Inhibition
91.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
02:34Inhibition of Cdk Activity
5.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.8K